Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,690 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 637
Recruiting: 366
Ph III recruiting: 20
Growth YoY: −13.8%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (367)

clinicaltrialsPublishedShowing 1,901–1,950 of 2,690 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02472184	Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy	completed	N/A	78	University of South FloridaOTHER	1	Sep 26, 2018	clinicaltrials
NCT03676985	A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma	unknown	Phase 1 / Phase 2	15	Lee's Pharmaceutical LimitedINDUSTRY	1	Sep 26, 2018	clinicaltrials